Taconic Biosciences is a private biotechnology company specializing in genetically engineered mouse and rat models, microbiome, immuno-oncology mouse models, and integrated model design and breeding services. The company was founded in 1952 as Taconic Farms. The company has three service laboratories and six breeding facilities in the U.S. and Europe, and is headquartered in Rensselaer, New York.[1][2]

Company overview

Taconic Biosciences is a breeder and supplier of laboratory animals operating in over 50 countries.[3] The current CEO is Nancy J. Sandy.[4] As of 2016, the company has over 800 employees and 1300 customers.[5]

They produce selectively bred and genetically engineered mice and rats for research use.[6]

History

  • 1949 – Robert Phelan began shipping mice from his garage in Canajoharie, NY.
  • 1952 – Taconic Farms is officially founded in Germantown, NY.
  • 1955 – Robert dies, leaving the company to his wife, Sally, and sons, Joseph, Richard, and Samuel.
  • 1963 – Contracted to provide BDF1 mice for the National Cancer Institute.
  • 1969 – Began offering rats, including Sprague Dawley, one of the most popular breeds of laboratory rat
  • 1969 – Taconic was the first breeder to receive full accreditation from the American Association for the Accreditation of Laboratory Animals
  • 1970 – Contracted to provide the National Institutes of Health with Sprague Dawley rats. They continue to supply NCI with BDF1 mice.
  • 1975 – Began offering the SHR hypertensive rat and the WKY control strain.
  • 1980 – Taconic developed the first Isolated Barrier Unit system, a method of housing rodents in a pathogen-free environment.
  • 1982 – Began offering Fischer 344 rats and asthmatic rats from Merck-Frost, Montreal, to the product offerings.
  • 1985 – Contracted to supply MPF and germ-free animals for the NASA space shuttle missions.[7]
  • 1985 – Started producing BALB/c mice.
  • 1991 – Became the first commercial provider of the C.B-17 SCID mouse model.
  • 1994 – Contracted with National Institute for Allergy and Infectious Disease to maintain a repository of inbred, congenic, and transgenic mice.
  • 2002 – Expanded business to Europe
  • 2014 – Name changed from Taconic Farms to Taconic Biosciences[5]
  • 2019 – Acquired by H.I.G. Capital[8]
  • 2022 - Acquired by Avista Capital Partners[9]

Acquisitions

In 2001, the company announced it acquired Anmed Laboratories.

In 2002, Taconic announced it acquired M&B Breeding (Denmark).[10]

In December 2009, the company announced it acquired Xenogen Biosciences. [11]

References

  1. ↑ "Taconic Biosciences Inc Company Profile and News". Bloomberg.com. 12 July 2021.
  2. ↑ Taconic Biosciences. "About Us | Taconic Biosciences". Taconic.com. Retrieved 2017-05-22.
  3. ↑ "Taconic Biosciences | Lab Animal Buyers' Guide". Guide.labanimal.com. Retrieved 2017-05-22.
  4. ↑ "Nancy J. Sandy Appointed Chief Executive Officer of Taconic Biosciences". 31 January 2019.
  5. 1 2 Taconic Biosciences. "Taconic Company History | Taconic Biosciences". Taconic.com. Retrieved 2017-05-22.
  6. ↑ "Taconic Biosciences, Inc.: Private Company Information". Bloomberg. 2017-04-17. Retrieved 2017-05-22.
  7. ↑ "Mice in microgravity: how rodent research in space accelerates study timelines". outsourcing-pharma.com. Retrieved 9 June 2017.
  8. ↑ "H.I.G. buys Taconic Biosciences". PEHub.com. 12 July 2021.
  9. ↑ Biosciences, Taconic. "Avista Capital Partners Acquires Taconic Biosciences". www.taconic.com. Retrieved 2023-08-25.
  10. ↑ "Taconic Acquires Denmark Breeder". Albany Business Review. Retrieved 1 May 2002.
  11. ↑ "Caliper sells animal models subsidiary to Taconic Farms for $11 million". Drug Discovery News. Retrieved 13 December 2009.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.